Jacobs Levy Equity Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,641
| Closed | -$249K | – | 1175 |
|
|
2020
Q4 | $249K | Sell |
14,641
-172,856
| -92% | -$2.94M | ﹤0.01% | 945 |
|
|
2020
Q3 | $881K | Sell |
187,497
-29,494
| -14% | -$139K | 0.01% | 688 |
|
|
2020
Q2 | $1.32M | Buy |
216,991
+205,576
| +1,801% | +$1.25M | 0.01% | 611 |
|
|
2020
Q1 | $26K | Sell |
11,415
-349,884
| -97% | -$797K | ﹤0.01% | 991 |
|
|
2019
Q4 | $1.66M | Buy |
361,299
+240,056
| +198% | +$1.1M | 0.02% | 579 |
|
|
2019
Q3 | $470K | Buy |
121,243
+82,983
| +217% | +$322K | 0.01% | 724 |
|
|
2019
Q2 | $231K | Sell |
38,260
-29,687
| -44% | -$179K | ﹤0.01% | 854 |
|
|
2019
Q1 | $910K | Buy |
67,947
+13,500
| +25% | +$181K | 0.01% | 684 |
|
|
2018
Q4 | $506K | Hold |
54,447
| – | – | 0.01% | 729 |
|
|
2018
Q3 | $758K | Buy |
54,447
+10,457
| +24% | +$146K | 0.01% | 697 |
|
|
2018
Q2 | $695K | Buy |
43,990
+16,000
| +57% | +$253K | 0.01% | 737 |
|
|
2018
Q1 | $481K | Buy |
27,990
+5,000
| +22% | +$85.9K | 0.01% | 783 |
|
|
2017
Q4 | $504K | Buy |
+22,990
| New | +$504K | 0.01% | 751 |
|